155 related articles for article (PubMed ID: 6090762)
1. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
Niederle N; Schütte J; Krischke W; Seeber S; Schmidt CG
Klin Wochenschr; 1984 Aug; 62(16):783-6. PubMed ID: 6090762
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
Niederle N; Schütte J; Schmidt CG; Seeber S
Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
König HJ; Arnold E; Walter M; Sander U
Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Daugaard G; Hansen HH; Rørth M
Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
[TBL] [Abstract][Full Text] [Related]
5. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J
Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
Drings P; Kleckow M; Manke HG; Stiefel E
Onkologie; 1984 Aug; 7(4):202-4. PubMed ID: 6384861
[TBL] [Abstract][Full Text] [Related]
7. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
Elliott JA; Ahmedzai S; Hole D; Dorward AJ; Stevenson RD; Kaye SB; Banham SW; Stack BH; Calman KC
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1025-32. PubMed ID: 6540685
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
[TBL] [Abstract][Full Text] [Related]
9. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
Höfeler H; Höffken K; Niederle N; Schoetensack B; Wandl U; Kath R; Müller M; Schmidt CG
Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1961-6. PubMed ID: 3024948
[TBL] [Abstract][Full Text] [Related]
12. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
13. [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
González Larriba JL; Alberola V; Lianes P; Panizo A; Carrato A; Muñoz Quintana A; Cardenal F; Gracia JM; Moyano A; Díaz-Rubio E
Rev Clin Esp; 1994 Nov; 194(11):953-9. PubMed ID: 7846351
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Itri LM; Gralla RJ; Kelsen DP; Chapman RA; Casper ES; Braun DW; Howard JE; Golbey R; Heelan RT
Cancer; 1983 Mar; 51(6):1050-5. PubMed ID: 6185210
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
[TBL] [Abstract][Full Text] [Related]
18. [Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].
Akazawa S; Kitagawa H; Nakagawa T; Fujiki T; Kanda Y; Futatsuki K; Sampi K; Fujita K
Gan To Kagaku Ryoho; 1984 May; 11(5):1018-23. PubMed ID: 6539098
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group.
Paridaens R; Clarysse A; Rozencweig M; Rotmensz N; Heuson JC
Eur J Cancer Clin Oncol; 1985 May; 21(5):595-9. PubMed ID: 4040025
[TBL] [Abstract][Full Text] [Related]
20. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T; Brisgand D; Pujol JL; Douillard JY; Monnier A; Rivière A; Chomy P; Le Groumellec A; Ruffie P; Gottfried M; Gaspard MH; Chevreau C; Alberola V; Cigolari S; Besson F; Martinez A; Besenval M; Berthaud P; Tursz T
Bull Cancer; 1996 May; 83(5):385-94. PubMed ID: 8680091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
